From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Upcoming Events

- Online Controlled Substances Summit Virtual Meeting Public Session: July 25, 2024 | 11am-3pm (eastern)
Natural History Studies and Registries in the Development of Rare Disease Treatments Public Workshop: In-Person and Virtual

Past Events

Qualifying Biomarkers to Support Rare Disease Regulatory Pathways
- Advancing Psychedelic Clinical Study DesignVirtual Public Meeting Day 1: January 31, 2024 | 10am-2pm (eastern)
Front-of-Package Nutrition LabelingVirtual Public Meeting
Integrating Clinical Studies Into Health Care Delivery: Post-Market Evidence Generation for Medical ProductsVirtual Public Meeting
Strategies for Improving Public Understanding of FDA-Regulated Products Virtual Public Meeting
Mitigating Risks from Human Xylazine Exposure Public Meeting: In-person and Virtual 
- On September 12 and 13, the Foundation, in collaboration with the U.S. Food and Drug Administration, hosted a webinar to explore Good Clinical Practice Considerations for Trials with Pragmatic or Decentralized Features.
RAISE: Lessons Learned & Practical Applications for the Future June 15, 2023 2-4 pm ET  
RAISE: Reactions to Barriers, Facilitators, and Proposed Solutions Thursday, June 1, 2023 2-3 PM ET